Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check2 days agoChange DetectedA new revision tag, v3.6.2, was added and the old tag, v3.6.0, was removed. This indicates a minor update to the page's underlying system rather than changes to the study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a recruitment status note ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), while the Intervention/Treatment heading is standardized and the Revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check23 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small metadata update to the ClinicalTrials.gov entry.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This indicates a minor update to the page’s template/metadata without changing the study content or user-facing details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a non-content release update.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study content or page functionality.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.